Pembrolizumab Monotherapy Versus Combined Pembrolizumab and Chemotherapy for Advanced Non-Small-Cell Lung Cancer in First-Line Therapy: A Retrospective, Single Center Study

Autor:	T. Masuda, Mika Saigusa, H. Watanabe, K. Tamura, Hiromasa Nakayasu, Satoshi Takahashi, Taisuke Akamatsu, Kyohei Oishi, Yutaro Kishimoto, Kazuhiro Asada, Toshihiro Shirai, A. Yamamoto, Satoru Morita, Y. Tanaka
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Pembrolizumab medicine.disease Single Center First line therapy Internal medicine medicine Non small cell business Lung cancer
Zdroj:	A70. ADVANCES IN LUNG CANCER THERAPEUTICS.
DOI:	10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2459
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1ef1df16f67a06692f7cf3ab8094ec6d https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2459 Zobrazit plný text záznamu